29
Participants
Start Date
May 24, 2016
Primary Completion Date
October 27, 2017
Study Completion Date
July 26, 2018
MBN-101
MBN-101 is a locally administered, anti-infective drug product
Placebo
The placebo is comprised of the vehicle/excipients used to formulate MBN-101, but does not contain the active pharmaceutical ingredient
University of Pennsylvania, Philadelphia
LifeBridge Health, Inc., Baltimore
The University of Texas - Health Science Center & Medical School at Houston, Houston
Orthopedic Trauma Institute, University of California San Francisco, San Francisco
UCSF - Parnassus, San Francisco
OhioHealth Research Institute, Columbus
Lead Sponsor
Collaborators (1)
University of Pennsylvania
OTHER
University of California, San Francisco
OTHER
Medpace, Inc.
INDUSTRY
Congressionally Directed Medical Research Programs
FED
Microbion Corporation
INDUSTRY